AGO2 and cancer: Blocking Ago2/CAV1 interaction in cancer cells with P2 peptides decreased the numbers of tumorsphere-forming cells in the A549 cancer cell populations (Fig. 4Di) and HCC1806 cancer cell populations (Fig. 4Dii).